PIEPER STEVEN (Chief Financial Officer) purchased 15.8% of their position (25K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $49.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/12/2021ACC: 0001867096-21-000075
Officer· Chief Financial Officer
Since Oct 2021
+25K
Net shares
Net buyer
$49.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
$2.00
Trade value
$49.92K
% of position
15.8%
11/10/2021
158.11K→183.11K
Total
Net shares
+25K
Net value
$49.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2021 | P · Purchase | +25K | $2.00 | $49.92K | 15.8% | 158.11K | 183.11K |
| Total | +25K | $49.92K | ||||||
Derivative Transactions0
No derivative transactions reported